STAAR Surgical has two patents on the technology to enhance flow within the eye and is pursuing additional claims to further broaden its intellectual property position.
The V4c design incorporates a proprietary port in the center of the ICL optic of a size determined to optimize the flow of fluid within the eye, and eliminates the need for the surgeon to perform a YAG peripheral iridotomy procedure days before the ICL implant.
Both myopic and myopic toric models of the ICL will feature the new design.
The V4c model has been approved in the -0.5 diopter to -18.0 diopters myopic range and +0.5 cylinder power to +6.0 for the Toric ICL models.
The clinical results showed that eyes with the V4c design had the same intraocular pressure (IOP) post operatively as the fellow eyes with the current ICL model.
STAAR Surgical plans to first engage a pre-market release of the product in four sites and 100 eyes before a full launch to the markets that accept CE Mark approvals.
STAAR Surgical CEO Barry Caldwell said the V5 model is currently underway with their research and development team and the concept designs for the V6 model are in the feasibility phase.
